Too Many Breast Cancer Survivors Miss Out on Genetic Screening
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
FRIDAY, July 19, 2024 -- Many breast cancer patients aren’t getting genetic counseling and testing that could help them get the most effective treatment, a new study finds.
Only three-quarters of patients eligible for genetic testing after their breast cancer diagnosis actually received it, researchers reported July 15 in the Journal of Clinical Oncology.
Further, just over half of breast cancer survivors eligible for testing during follow-up care received a genetic screening.
“Our findings support a rapidly growing movement to simplify clinical guidelines to increase access to genetic testing and clinical impact of the results after diagnosis and into survivorship,” said lead researcher Dr. Steven Katz, a professor of internal medicine and of health management and policy at the University of Michigan.
Certain genetic mutations can increase a woman’s risk for breast cancer, the American Cancer Society says. The best-known are BRCA gene mutations, which cause 5% to 10% of breast cancers and for which specific treatments have been developed.
Genetic tests can help guide treatment, as well as follow-up care and screening, researchers said. The results can also be used to warn other family members of potential increased risk for cancer.
For this study, researchers surveyed more than 1,400 women at seven months and at six years after they were diagnosed with early-stage breast cancer.
The team found many women aren’t getting the gene testing for which they’re eligible, both at diagnosis and following treatment.
“Genetic risk evaluation and testing can fall through the cracks during survivorship as patients’ needs for ongoing treatments, managing the side effects of treatments and monitoring for recurrence or progression grow,” senior researcher Lauren Wallner, an associate professor of internal medicine and epidemiology at Michigan, said in a university news release.
At the same time, about a third of patients for whom genetic testing wouldn’t be recommended got it anyway, results showed.
There was some good news -- among those who got testing, nearly two-thirds who had a genetic variant reached out to family members to talk about their results, researchers said.
Results also showed that few people are interested in direct-to-consumer genetic tests, which are not as sophisticated as genetic testing and counseling at hospitals and clinics, researchers said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-19 23:15
Read more
- ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
- AAO: Prior Intravitreal Injections Increase Risk for Cataract Surgery Complications
- COVID-19 Pandemic-Linked Increase in Alcohol Use Persisting
- How Would Billing for Secure Messages Impact Patients, Physicians?
- Want to Slowly Cut Down on Dietary Salt? Here's How
- NIH Trial of Rectal Microbicide for HIV Prevention Begins in the United States
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions